CATALOGO DEI PRODOTTI DELLA RICERCA

DE MANZONI, Giovanni
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.320
EU - Europa 12.286
AS - Asia 8.769
SA - Sud America 1.169
AF - Africa 357
OC - Oceania 35
Continente sconosciuto - Info sul continente non disponibili 15
AN - Antartide 1
Totale 34.952
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.080
RU - Federazione Russa 4.713
SG - Singapore 3.655
GB - Regno Unito 2.785
CN - Cina 2.495
IT - Italia 1.223
BR - Brasile 945
HK - Hong Kong 782
VN - Vietnam 743
DE - Germania 651
SE - Svezia 647
FR - Francia 609
IE - Irlanda 583
FI - Finlandia 454
KR - Corea 314
UA - Ucraina 174
TR - Turchia 123
CA - Canada 115
JP - Giappone 114
IN - India 101
NL - Olanda 85
NG - Nigeria 81
ES - Italia 76
AR - Argentina 73
MX - Messico 73
BD - Bangladesh 64
IQ - Iraq 60
AT - Austria 55
ZA - Sudafrica 55
ID - Indonesia 54
TG - Togo 48
PL - Polonia 41
BE - Belgio 40
BJ - Benin 38
EC - Ecuador 38
AU - Australia 31
UZ - Uzbekistan 31
PK - Pakistan 29
PY - Paraguay 28
CO - Colombia 25
RW - Ruanda 22
CZ - Repubblica Ceca 21
EG - Egitto 21
JO - Giordania 21
IL - Israele 20
LT - Lituania 20
AE - Emirati Arabi Uniti 18
CL - Cile 18
KE - Kenya 17
PH - Filippine 17
SA - Arabia Saudita 17
VE - Venezuela 17
IR - Iran 16
MA - Marocco 15
KG - Kirghizistan 14
NO - Norvegia 14
DZ - Algeria 12
PT - Portogallo 12
UY - Uruguay 12
MY - Malesia 11
PA - Panama 11
TN - Tunisia 11
GR - Grecia 10
AL - Albania 9
EU - Europa 9
LV - Lettonia 9
PE - Perù 9
AO - Angola 7
BG - Bulgaria 7
CR - Costa Rica 7
ET - Etiopia 7
KZ - Kazakistan 7
OM - Oman 7
TW - Taiwan 7
AZ - Azerbaigian 6
CH - Svizzera 6
HN - Honduras 6
JM - Giamaica 6
DO - Repubblica Dominicana 5
LB - Libano 5
RO - Romania 5
SN - Senegal 5
TH - Thailandia 5
TT - Trinidad e Tobago 5
XK - ???statistics.table.value.countryCode.XK??? 5
AM - Armenia 4
BH - Bahrain 4
BY - Bielorussia 4
GE - Georgia 4
GT - Guatemala 4
HR - Croazia 4
HU - Ungheria 4
MK - Macedonia 4
PS - Palestinian Territory 4
SI - Slovenia 4
BO - Bolivia 3
BZ - Belize 3
CI - Costa d'Avorio 3
CM - Camerun 3
CY - Cipro 3
Totale 34.897
Salva come PNG Salva come JPEG
Città #
Southend 2.395
Singapore 1.938
Moscow 1.510
Ashburn 1.402
San Jose 1.204
Jacksonville 1.156
Chandler 1.142
Dallas 980
Hong Kong 774
Woodbridge 699
Verona 672
Dublin 578
Ann Arbor 460
Beijing 423
The Dalles 408
Houston 322
New York 282
Ho Chi Minh City 272
Los Angeles 233
Lawrence 204
Princeton 204
Wilmington 199
Jinan 182
Hanoi 164
Nanjing 157
Munich 141
Shenyang 140
Redmond 132
Buffalo 116
Helsinki 111
Milan 102
Tokyo 102
Hebei 100
Sindelfingen 97
São Paulo 91
London 84
Redondo Beach 80
Abuja 78
Santa Clara 78
Columbus 77
Council Bluffs 75
Tianjin 74
Changsha 69
Nanchang 62
Seoul 60
Zhengzhou 60
Haikou 56
Guangzhou 55
Amsterdam 52
Orem 52
Seattle 50
Jiaxing 48
Lomé 48
Ningbo 47
Frankfurt am Main 46
Boardman 43
Stockholm 41
Atlanta 40
Brussels 40
Chicago 40
Montreal 40
Taizhou 39
Cotonou 38
Hangzhou 38
Brooklyn 37
San Francisco 36
Turku 36
Denver 35
Vienna 34
Warsaw 34
Nuremberg 33
Johannesburg 32
Rome 32
Rio de Janeiro 31
Dearborn 30
Madrid 29
Norwalk 28
Baghdad 27
Tashkent 26
Toronto 26
Boston 25
Mexico City 25
Phoenix 25
Chennai 24
Haiphong 24
Manchester 24
Lappeenranta 23
Belo Horizonte 22
Jakarta 22
Kigali 22
Taiyuan 22
Curitiba 21
Dong Ket 21
Fuzhou 21
Paris 21
Poplar 21
Redwood City 21
Amman 20
Da Nang 20
Lanzhou 20
Totale 21.652
Salva come PNG Salva come JPEG
Nome #
An FGFR3 autocrine loop sustains acquired resistance to trastuzumab in gastric cancer patients 315
Extranodal extension of lymph node metastasis is a marker of poor prognosis in oesophageal cancer: a systematic review with meta-analysis 294
A clinical-biological risk stratification model for resected gastric cancer: prognostic impact of Her2, Fhit, and APC expression status 285
[Preliminary results of neoadjuvant treatment of adenocarcinoma of the gastro-esophageal junction]. 260
Genomic characterization of hepatoid tumors: context matters 260
Comprehensive molecular portrait using next generation sequencing of resected intestinal-type gastric cancer patients dichotomized according to prognosis 253
High-throughput mutation profiling identifies novel molecular dysregulation in high-grade intraepithelial neoplasia and early gastric cancers 225
Anastomotic leak following oesophagectomy: research priorities from an international Delphi consensus study 217
Persistent excess mortality from lung cancer in patients with stage I non-small-cell lung cancer, disease-free after 5 years 215
Impact of super-extended lymphadenectomy on relapse in advanced gastric cancer. 205
Family history of gastric cancer: a correlation between epidemiologic findings and clinical data. 205
[Advanced gastric adenocarcinoma with RER+ phenotype presents a good prognosis after 5 years of curative resection] 205
Extension of lymphadenectomy for gastric cancer:Audit at European specialist centres. 200
Pediatric Palliative Care: Historical Origins and a Glimpse into Ethical Issues 199
ypN0: Does It Matter How You Get There? Nodal Downstaging in Esophageal Cancer 199
Adenocarcinoma of the esophagogastric junction 199
A phase II trial of the FGFR inhibitor pemigatinib in patients with metastatic esophageal-gastric junction/gastric cancer trastuzumab resistant: the FiGhTeR trial 198
Loss of Fhit expression is associated with poorer survival in gastric cancer but is not an independent prognostic marker 195
Acute hemorrhage secondary to gastric ulcer. Results of emergency endoscopic treatment in 775 cases. 195
hERG1 channels regulate VEGF-A secretion in human gastric cancer: clinicopathological correlations and therapeutical implications. 193
The amount of signet ring cells is significantly associated with tumour stage and survival in gastric poorly cohesive tumours 193
The Italian Research Group for Gastric Cancer (GIRCG) guidelines for gastric cancer staging and treatment: 2015 192
Clinical pathways in gastric cancer care 191
Morphological and Functional Changes in the Peritumoral Adipose Tissue of Colorectal Cancer Patients 189
Emergency sclerotherapy in esophageal and gastric acutely variceal bleeding : ten years expérience (1988-1997). 189
Valutazione dell’applicabilità del modello organizzativo della weeksurgery alle Chirurgia Generale di un Presidio di un’AziendaOspedaliera del Veneto 188
Extranodal Extension of Nodal Metastases Is a Poor Prognostic Indicator in Gastric Cancer: a Systematic Review and Meta-analysis 187
Molecular Analysis of an Intestinal Neuroendocrine/Non-neuroendocrine Neoplasm (MiNEN) Reveals MLH1 Methylation-driven Microsatellite Instability and a Monoclonal Origin: Diagnostic and Clinical Implications 187
Enhanced recovery after surgery protocol in patients undergoing esophagectomy for cancer: a single center experience 185
Enhanced recovery protocol in esophagectomy, is it really worth it? A cost analysis related to team experience and protocol compliance 183
Changing clinical and pathological features of gastric cancer over time. 182
Valutazione di uno screening colonscopico in pazienti ad alto rischio di CRC 181
The analysis of PIK3CA mutations in gastric carcinoma and metanalysis of literature suggest that exon-selectivity is a signature of cancer type 181
Via biliare principale, pancreatite acuta e chirurgia mini-invasiva. 180
Peritoneal cytology does not increase the prognostic information provided by TNM in gastric cancer. 179
A new way to experience the International Gastric Cancer Association congress: the Web Round Tables 177
Textbook outcome following oesophagectomy for cancer: international cohort study 175
Response to induction therapy in oesophageal and cardia carcinoma using Mandard tumour regression grade or size of residual foci 174
Targeted therapies for advanced and metastatic adenocarcinoma of the gastroesophageal junction: is there something new? 173
Is there any role for super-extended limphadenectomy in advanced gastric cancer? results of an observational study from a western high volume center 172
Microsatellite instability in gastric cancer is associated with better prognosis only in stage II cancers 171
Comparison of old and new TNM systems for nodal staging in adenocarcinoma of the gastro-oesophageal junction 171
TAK1-regulated expression of BIRC3 predicts resistance to preoperative chemoradiotherapy in oesophageal adenocarcinoma patients 170
A national survey on the current status of minimally invasive gastric practice on behalf of GIRCG 168
Short-term and long-term risk factors in gastric cancer 167
Effectiveness of endoscopic vacuum therapy as rescue treatment in refractory leaks after gastro-esophageal surgery 167
Endoscopic submucosal dissection in the treatment of gastric submucosal tumors: results from a retrospective cohort study. 166
[Treatment of the peritoneal carcinomatosis by cytoreductive surgery and intraperitoneal hyperthermic chemotherapy (IHPC): postoperative morbidity and mortality and short-term follow-up] 165
Authors' reply: Response to induction therapy in oesophageal and cardia carcinoma using Mandard tumour regression grade or size of residual foci (letter) 164
18F-FDG PET/CT Metrics Are Correlated to the Pathological Response in Esophageal Cancer Patients Treated With Induction Chemotherapy Followed by Neoadjuvant Chemo-Radiotherapy 163
Lymphadenectomy for gastric cancer at European specialist centres 162
[Patterns of transition between lymphangioma and intestinal lymphangiectasia. RAdiologic and histologic aspects of 2 cases with predominant involvement of the colon]. 161
Lack of an association between circulating adiponectin levels and risk of colorectal adenoma. 161
Neoadjuvant Concurrent Chemoradiotherapy for Locally Advanced Esophageal Cancer in a Single High-Volume Center. 161
Experience on complex incisional hernia treatment in septic patients 161
Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in pseudomyxoma peritonei of appendiceal origin: result of a single centre study 161
Pressurized intraperitoneal aerosol chemotherapy (PIPAC) in multimodal therapy for patients with oligometastatic peritoneal gastric cancer: a randomized multicenter phase III trial PIPAC VEROne 159
Perianal Paget's disease: presentation of six cases and literature review. 159
Enhanced Recovery After Surgery can Improve Patient Outcomes and Reduce Hospital Cost of Gastrectomy for Cancer in the West: A Propensity-Score-Based Analysis 159
High pathological response rate in locally advanced esophageal cancer after neoadjuvant combined modality therapy: dose finding of a weekly chemotherapy schedule with protracted venous infusion of 5-fluorouracil and dose escalation of cisplatin, docetaxel and concurrent radiotherapy. 158
Conversion gastrectomy for stage IV unresectable gastric cancer: a GIRCG retrospective cohort study 158
Factors influencing survival after hepatectomy for metastases from gastric cancer 157
The value of in vitro ultrasonography in the intraoperative staging of gastric cancer. Blind study of 93 cases. 156
Perigastric lymph node metastasis in gastric cancer: comparison between different staging systems 156
Tumor Site and Perigastric Nodal Status are the Most Important Predictors of Para-Aortic Nodal Involvement in Advanced Gastric Cancer 156
Using the Angio-Seal to Achieve Hemostasis in Prosthetic Endovascular Surgery: Report of Three Cases 156
Long-Term Outcomes of Induction Chemotherapy Followed by Chemo-Radiotherapy as Intensive Neoadjuvant Protocol in Patients with Esophageal Cancer 155
Complications after gastrectomy for cancer: Italian perspective 153
Poorly Cohesive Gastric Cancers Showing the Transcriptomic Hallmarks of Epithelial-Mesenchymal Transition Behave Aggressively 153
Western strategy for EGJ carcinoma 152
Endoscopic ablation of Barrett's esophagus using high power setting argon plasma coagulation: a prospective study 150
Biomarkers of myocardial infarction in patients undergoing gastrointestinal cancer surgery 150
Management of critically ill surgical patients Case reports 150
Multicenter Study of Presentation, Management, and Postoperative and Long-Term Outcomes of Septegenerians and Octogenerians Undergoing Gastrectomy for Gastric Cancer 150
Surgical treatment of gastric cancer with coexistent abdominal aortic aneurysm. Personal experience and literature review 149
Krukenberg Tumors of Gastric Origin: The Rationale of Surgical Resection and Perioperative Treatments in a Multicenter Western Experience 148
Genetic prediction of long-term survival after neoadjuvant chemoradiation in locally advanced esophageal cancer 147
Preliminary Experience with Prophylactic Thoracic Endovascular Aortic Repair in Patients Affected by Advanced Esophageal Cancer 147
Effect of Pyloroplasty on Gastric Conduit Emptying and Patients' Quality of Life After Ivor Lewis Esophagectomy 147
Core outcome set for surgical trials in gastric cancer (GASTROS study): international patient and healthcare professional consensus 146
Induction chemio-radiotherapy for squamous cell carcinoma of the thoracic esophagus: long-term results of a phase 2 study 146
Lymphadenectomy: how to do it? 146
Iatrogenic axillary artery injury from humeral neck fracture repair. A rare and unusual event in which and aggressive strategy was mandatory to save a child limb 145
Proximal Gastrectomy: Technical Notes 145
Incidence and Prognostic Value of Metastases to "Posterior" and Para-aortic Lymph Nodes in Resectable Gastric Cancer 145
The amount of cells with Signet Ring Cell morphology has a prognostic impact in poorly cohesive gastric carcinoma 144
Strengths and Limitations of the Evidence-Based Movement Aimed to Improve Clinical Outcomes in Dentistry and Oral Surgery 144
Current practice on the use of prophylactic drain after gastrectomy in Italy: the Abdominal Drain in Gastrectomy (ADiGe) survey 143
Lymphatic spread, lymph node stations, and levels of lymphatic dissection in gastric cancer 143
Clinical Features of Gastric Signet Ring Cell Cancer: Results from a Systematic Review and Meta-Analysis 142
Endosonography in esophageal cancer staging after preoperative chemo and radiotherapy. 142
ASO Visual Abstract: Bidirectional Approach with PIPAC and Systemic Chemotherapy for Patients with Synchronous Gastric Cancer Peritoneal Metastases (GCPM) 141
Evaluation of Siewert classification in gastro-esophageal junction adenocarcinoma: What is the role of endoscopic ultrasonography? 141
hERG1 behaves as biomarker of progression to adenocarcinoma in Barrett's esophagus and can be exploited for a novel endoscopic surveillance 139
Comparison of short-term outcomes from the International Oesophago-Gastric Anastomosis Audit (OGAA), the Esophagectomy Complications Consensus Group (ECCG), and the Dutch Upper Gastrointestinal Cancer Audit (DUCA) 138
Bidirectional Approach with PIPAC and Systemic Chemotherapy for Patients with Synchronous Gastric Cancer Peritoneal Metastases (GCPM) 138
Staging and treatment of gastric cancer 138
Induction chemo-radiotherapy for squamous cell carcinoma of the thoracic esofagus: impact of increased dosage on long-term results. 138
Esophageal surgery in Italy. Criteria to identify the hospital units and the tertiary referral centers entitled to perform it 138
Early Gastric Cancer: Clinical Behavior and Treatment Options. Results of an Italian Multicenter Study on Behalf of the Italian Gastric Cancer Research Group (GIRCG) 138
Totale 17.319
Salva come PNG Salva come JPEG
Categoria #
all - tutte 116.259
article - articoli 104.179
book - libri 1.561
conference - conferenze 6.243
curatela - curatele 0
other - altro 630
patent - brevetti 0
selected - selezionate 0
volume - volumi 3.646
Totale 232.518
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021362 0 0 0 0 0 0 0 0 0 95 208 59
2021/20221.520 93 382 37 129 83 39 40 111 53 53 121 379
2022/20233.544 242 310 327 622 297 867 14 255 384 27 88 111
2023/20242.015 58 167 170 254 219 321 108 110 25 121 351 111
2024/20255.515 295 333 273 846 267 183 400 291 747 453 417 1.010
2025/202614.875 1.093 746 971 2.510 3.896 1.121 1.574 897 1.242 825 0 0
Totale 35.287